Very high prevalence of hepatitis b and c in bukharian jewish immigrants to israel

Journal of Clinical Gastroenterology

Volumn 24, Issue 1, 1997, Pages 30-33

  Glikberg, Frida ^a   Brawer Ostrovsky, Judith ^a   Ackerman, Zvi ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Bukhar; Hepatitis B; Hepatitis C; Israel; Tajikistan; U.S.S.R.; Uzbekistan

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; IMMIGRANT; ISRAEL; JEW; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TAJIKISTAN; UZBEKISTAN;

ADOLESCENT; ADULT; AGED; EMIGRATION AND IMMIGRATION; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; ISRAEL; JEWS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; TAJIKISTAN; UZBEKISTAN;

EID: 0031031978     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199701000-00006     Document Type: Article

References (24)

1. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus human non-A non-B hepatitis. Science 1989;244:362-4.
2. Hasan F, Jeffers LJ, Demedina M, et al. Hepatitis C associated hepatocellular carcinoma. Hepatology 1990;12:589-91.
3. Alter MJ. Transmission of hepatitis C virus: route, dose and titer. N Engl J Med 1994;330:784-6.
4. Kuhnll P, Seidl S, Stangel W, Beyer J, Sibrowski W, Flik J. Antibody to hepatitis C virus in German blood donors. Lancet 1989;2:324.
5. Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989;2:294-6.
6. Sirchia G, Bellobuono A, Giovanetti A, Marconi M. Antibodies in hepatitis C virus in Italian blood donors. Lancet 1989;2:797.
7. Thomas HC. The role of interferons in chronic viral hepatitis. In: Kane MA, ed. Consultant series no. 2. U.K.: Gardiner-Caldwell Communications Ltd., 1994.
8. Laskus T, Radowski M, Lupa E, et al. Hepatitis C virus antibody in Poland. Scand J Infect Dis 1991;23:385-6.
9. Scott DA, Constantine NT, Callahan J. The epidemiology of hepatitis C virus antibody in Yemen. Am J Trop Med Hyg 1992;46:63-8.
10. Ngatchu T, Stroffolini T, Rapicetta M. Seroprevalence of anti-HCV in an urban child population: a pilot survey in a developing area, Cameroon. J Trop Med Hyg 1992;95:57-61.
11. Stern M, Manny N, Klein A, Naparstek Y, Shraga S, Tur-Kaspa R. A study of Israeli blood donors, asymptomatic carriers of hepatitis C virus in relation to liver disease, cryoglobulinemia and transmission. Isr J Med Sci 1995;31:277-9.
12. Bar-Shany S, Green MS, Slepon R, Shinar E. Ethnic differences in the prevalence of anti-hepatitis C antibodies and hepatitis B surface antigen in Israeli blood donors by age, sex, country of birth and origin. J Viral Hepatitis 1995;2:139-14.
13. Zubin M. Samarkand county's Jews in 1979. Peamim [Studies in the Cultural Heritage of Oriental Jewry] 1988;35:170-97.
14. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 1993;49:440-7.
15. Iashina TL, Favorov MO, Shakhgildian IV, et al. The spread of hepatitis C markers among the population of regions of Russia and Central Asia. ZH Mikrobiol Epidemiol Immunobiol 1993;5:46-9.
16. Lytsar BN, Skvortsov SV, Poliakova II, Lobanova VIU, Belov EV Detection of antibodies to hepatitis C virus in blood donors. Gematol Transfuziol 1993;38:29-31.
17. Shakhgildian IV, Onishchenko GG, Khukhlovich PA, Ananev VA, Kuzin SN, Klimenko SM. Study results and the unresolved problems in the epidemiology and prevention of parenteral viral hepatitis in Russia. ZH Mikrobiol Epidemiol Immunobiol 1994;5: 26-32.
18. Isacsohn M, Halevy J, Eidelman AI, Rudensky B, Tadmor OP, Slater PE. Prevalence of HBsAg carriers in pregnant women in Jerusalem: risk for horizontal transmission to family members. Isr J Med Sci 1994;30:368-70.
19. Yoshizawa H, Itoh Y, Iwakiri S, et al. Non-A non-B (type 1) hepatitis agent capable of inducing tubular ultrastructures in the hepatocyte cytoplasm of chimpanzees: inactivation by formalin and heat. Gastroenterology 1982;82:502-6.
20. Shikata T, Karasawa T, Abe K, et al. Hepatitis B antigen and infectivity of hepatitis B virus. J Infect Dis 1977;136:571-6.
21. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991;14:969-74.
22. Waked IA, Saleh SM, Moustafa MS, Raouf AA, Thomas DL, Strickland GT. High prevalence of hepatitis C in Egyptian patients with chronic liver disease. Gut 1995;37:105-7.
23. Tsega E, Nordenfelt E, Hansson BG. Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic. Trans R Soc Trop Med Hyg 1995;89:171-4.
24. Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991;14:64-7.